BioNexus Gene Lab Corp. (BGLC)

USD 0.26

(-2.99%)

Total Debt Summary of BioNexus Gene Lab Corp.

  • BioNexus Gene Lab Corp.'s latest annual total debt in 2023 was 133.39 Thousand USD , up 134.95% from previous year.
  • BioNexus Gene Lab Corp.'s latest quarterly total debt in 2024 Q2 was 235.9 Thousand USD , up 94.4% from previous quarter.
  • BioNexus Gene Lab Corp. reported annual total debt of 56.77 Thousand USD in 2022, down -26.22% from previous year.
  • BioNexus Gene Lab Corp. reported annual total debt of 76.94 Thousand USD in 2021, down -37.65% from previous year.
  • BioNexus Gene Lab Corp. reported quarterly total debt of 121.35 Thousand USD for 2024 Q1, down -9.03% from previous quarter.
  • BioNexus Gene Lab Corp. reported quarterly total debt of 45.75 Thousand USD for 2023 Q2, down -12.69% from previous quarter.

Annual Total Debt Chart of BioNexus Gene Lab Corp. (2023 - 2016)

Historical Annual Total Debt of BioNexus Gene Lab Corp. (2023 - 2016)

Year Total Debt Total Debt Growth
2023 133.39 Thousand USD 134.95%
2022 56.77 Thousand USD -26.22%
2021 76.94 Thousand USD -37.65%
2020 123.41 Thousand USD 38.0%
2019 89.43 Thousand USD 8.98%
2018 82.06 Thousand USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%

Peer Total Debt Comparison of BioNexus Gene Lab Corp.

Name Total Debt Total Debt Difference
Bionano Genomics, Inc. 87.94 Million USD 99.848%
Prenetics Global Limited 2.36 Million USD 94.37%
Star Equity Holdings, Inc. 3.6 Million USD 96.304%
CareDx, Inc 34.22 Million USD 99.61%
Exact Sciences Corporation 2.55 Billion USD 99.995%
Exagen Inc. 23.72 Million USD 99.438%
Inotiv, Inc. 417.64 Million USD 99.968%
Guardant Health, Inc. 1.35 Billion USD 99.99%
Biodesix, Inc. 60.69 Million USD 99.78%
Precipio, Inc. 1.11 Million USD 88.047%
iSpecimen Inc. 196.24 Thousand USD 32.026%
Natera, Inc. 441.99 Million USD 99.97%
Aspira Women's Health Inc. 2.26 Million USD 94.113%
Standard BioTools Inc. 98.21 Million USD 99.864%
23andMe Holding Co. 76.51 Million USD 99.826%
Castle Biosciences, Inc. 15.31 Million USD 99.129%
Personalis, Inc. 48.96 Million USD 99.728%
Aclaris Therapeutics, Inc. 426 Thousand USD 68.687%
Applied DNA Sciences, Inc. 1.23 Million USD 89.223%
OpGen, Inc. 13.04 Million USD 98.977%
T2 Biosystems, Inc. 49.49 Million USD 99.731%
Myriad Genetics, Inc. 145 Million USD 99.908%
ICON Public Limited Company 3.93 Billion USD 99.997%
NeoGenomics, Inc. 611.67 Million USD 99.978%
Star Equity Holdings, Inc. 3.6 Million USD 96.304%
IDEXX Laboratories, Inc. 947.88 Million USD 99.986%
RadNet, Inc. 1.49 Billion USD 99.991%
MDxHealth SA 41.26 Million USD 99.677%
Psychemedics Corporation 2.29 Million USD 94.195%
Illumina, Inc. 2.26 Billion USD 99.994%
Check-Cap Ltd. - USD -Infinity%
Twist Bioscience Corporation 94.06 Million USD 99.858%
DarioHealth Corp. 29.54 Million USD 99.548%
Fulgent Genetics, Inc. 14.9 Million USD 99.105%
Sera Prognostics, Inc. 1.85 Million USD 92.821%
ENDRA Life Sciences Inc. 394.4 Thousand USD 66.178%
OPKO Health, Inc. 326.56 Million USD 99.959%
Medpace Holdings, Inc. 142.12 Million USD 99.906%
Neogen Corporation 906.23 Million USD 99.985%
Intelligent Bio Solutions Inc. 871.44 Thousand USD 84.693%
Prenetics Global Limited 2.36 Million USD 94.37%
Mainz Biomed B.V. 7.42 Million USD 98.202%
bioAffinity Technologies, Inc. 1.57 Million USD 91.55%
Trinity Biotech plc 67.42 Million USD 99.802%
Neuronetics, Inc. 62.47 Million USD 99.786%
Sotera Health Company 2.32 Billion USD 99.994%
bioAffinity Technologies, Inc. 1.57 Million USD 91.55%